HomeAI · summaries
Storia in 2 fonti
Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies
Novo Nordisk is launching a cheaper authorised Ozempic copy in South Africa as it battles compounded drugs, generics and Eli Lilly for control of the country’s fast-growing GLP-1 market
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
businessday.co.za
India’s Sun Pharma wins South Africa approval to launch generic Ozempic
South Africa is now the second market, after India, where the company has secured clearance for a generic semaglutide injection
- ·
africa.businessinsider.com
Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies
Novo Nordisk is launching a cheaper authorised Ozempic copy in South Africa as it battles compounded drugs, generics and Eli Lilly for control of the country’s fast-growing GLP-1…